Læknablaðið - 15.08.1993, Blaðsíða 46

252
LÆKNABLAÐIÐ
Einkenni um kæfisvefn eru algeng bæði meðal
barna og fullorðinna. Ef gert er ráð fyrir að
lágmarkstíðni kæfisvefns meðal fullorðinna
sé á bilinu 1,3-2,5% þá eru að minnsta kosti
1000-2000 kæfisvefnssjúklingar hérlendis.
Því til viðbótar eru tvisvar til fjórum sinnum
fleiri sem eru með veruleg kæfisvefnseinkenni.
Meðal barna er málið nokkru flóknara en gera
má ráð fyrir að 500-800 börn hafi marktækar
öndunartruflanir í svefni. Þegar haft er í
huga hve afdrifaríkar afleiðingar kæfisvefn
getur haft á líðan, starfsgetu og lífshorfur, má
ljóst vera að greining og meðferð kæfisvefns
ætti að vera eitt af forgangsverkefnum
heilbrigðisþjónustunnar í baráttunni við
langvinna sjúkdóma.
HEIMILDIR
1. Guilleminault C, Cumminsky J, Dement WC. Sleep
Apnea Syndrome: Recent Advances. Adv Intern Med
1980; 26: 347-74.
2. Krieger J. Sleep apnea syndromes in adults. Bull Eur
Physiopathol Respir 1986; 22: 147-89.
3. Broadbent WH. Cheyne-Stoke’s respiration in
cerebral hemorrhage. Lancet 1877; 3: 307-9.
4. Lavie P. Nothing new under the moon. Historical
accounts of sleep apnea syndrome. Arch Intern Med
1984; 144: 2025-8.
5. Bæksted A. Goð og hetjur í heiðnum sið. Reykjavík:
Bókaútgáfan Örn og Örlygur, 1986; 105-11.
6. Krieger J, Laks L, Wilcox I, et al. Atrial natriuretic
peptide release in patients with obstructive sleep
apnea before and during treatment with nasal
continuous positive airway pressure. Clin Sci 1989;
77: 407-11.
7. Findley LJ, Fabrizio M, Thommi G, Suratt PM.
Severity of sleep apnea and automobile crashes. N
Engl J Med 1989; 320: 868-9.
8. Kales A, Caldwell AB, Cadieux RJ, et al. Severe
obstruclive sleep apnea. J Chron Dis 1985; 38: 427-
34.
9. Issa FG, Sullivan CE. Alcohol, snoring and sleep
apnea. J Neurol Neurosurg Psychiatry 1982; 45: 353-
9.
10. Mendelson WB, Gamett D, Gillin JC. Flurazepam
induced sleep apnea syndrome in a patient with
insomnia and mild sleep-related respiratory changes. J
Nerv Ment Dis 1981; 4: 261-4.
11. Orr WC, Males JL, Imes NK. Myxedema and
obstructive sleep apnea. Am J Med 1981; 70: 1061-6.
12. Hart TB, Scott KR, Blackard WG, St. George Tucker
H, Cooper KR. Sleep apnea in active acromegaly.
Arch Intern Med 1985; 145: 865-6.
13. Gislason T, Almqvist M, Erikson G, Taube A, Boman
G. Prevalence of sleep apnea syndrome among
Swedish men - an epidemiological study. J Clin
Epidemiol 1988; 41: 571-6.
14. Gislason T, Benediktsdóttir B, Bjömsson JK,
Kjartansson G, Kjeld M, Kristbjamarson H. Snoring,
hypertension and the sleep apnea syndrome -an
epidemiological survey of middle aged women. Chest
1993; 103: 1147-51.
15. Gislason T. Benediktsdottir B, Bjömsson JK,
Kristbjamarson H. Prevalence of sleep apnea
syndrome in Sweden and Iceland. In: Kuna ST, Suratt
PM, Remmers JE, eds. Sleep and respiration in aging
adults. Elsevier: Elsevier Science Publishing Co.,
1991: 137-43.
16. Kales A, Bixler E, Cadieux R, et al. Sleep apnea in
hypertensive jtopulalion. Lancet 1984; 2: 1005-8.
17. Gislason T. Aberg H, Taube A. Snoring and systemic
hypertension - an epidemiological study. Acta Med
Scand 1987; 222: 415-21.
18. Guilleminault C, Connolly SJ, Winkle R. Cardiac
arrhythmia and conduction disturbances during sleep
in 400 patients with sleep apnea syndrome. Am J
Cardiol 1983; 52: 490-4.
19. Hc J, Kryger MH, Zorick FJ, et al. Mortality and
apnea index in obstmctive sleep apnea. Experience
in 385 male palients. Chest 1988; 94: 9-14.
20. Partinen M, Jamieson A, Guilleminault C. Long-
term outcome for obstructive sleep apnea syndrome
patients; mortality. Chest 1988; 94: 1200-4.
21. Partinen M, Palomaki H. Snoring and cerebral
infarction. Lancet 1985; 2: 1325-6.
22. Hung J, Whitford EG, Parsons RW. Association
of sleep apnea with myocardial infarction in men.
Lancet 1990; 336: 261-4.
23. Orr WC. Snoring - A major health risk. Chest 1992;
101: 4: 889-90.